P3 Health Partners Inc. (PIIIW)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 860.96 Million USD | -1.78% |
| 2022 | 876.57 Million USD | -62.92% |
| 2021 | 2.36 Billion USD | 2266.42% |
| 2020 | 99.9 Million USD | 52.28% |
| 2019 | 65.6 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 892.75 Million USD | 4.3% |
| 2024 Q1 | 855.92 Million USD | -0.59% |
| 2023 Q2 | 908.95 Million USD | 4.79% |
| 2023 FY | 860.96 Million USD | -1.78% |
| 2023 Q4 | 860.96 Million USD | -4.01% |
| 2023 Q3 | 896.89 Million USD | -1.33% |
| 2023 Q1 | 867.42 Million USD | -1.04% |
| 2022 Q1 | 2.35 Billion USD | -0.32% |
| 2022 Q4 | 876.57 Million USD | -36.62% |
| 2022 FY | 876.57 Million USD | -62.92% |
| 2022 Q3 | 1.38 Billion USD | -4.23% |
| 2022 Q2 | 1.44 Billion USD | -38.72% |
| 2021 FY | 2.36 Billion USD | 2266.42% |
| 2021 Q4 | 2.36 Billion USD | 2911.4% |
| 2021 Q3 | 78.5 Million USD | -5.36% |
| 2021 Q1 | 317.69 Million USD | 198.49% |
| 2021 Q2 | 82.95 Million USD | -73.89% |
| 2020 Q4 | 106.43 Million USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2020 FY | 99.9 Million USD | 52.28% |
| 2019 FY | 65.6 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 5.35 Billion USD | 83.934% |
| Addus HomeCare Corporation | 1.02 Billion USD | 15.956% |
| AirSculpt Technologies, Inc. | 213.55 Million USD | -303.165% |
| Amedisys, Inc. | 2.06 Billion USD | 58.209% |
| American Oncology Network, Inc. | 374.45 Million USD | -129.927% |
| Astrana Health, Inc. | 933.36 Million USD | 7.756% |
| Aveanna Healthcare Holdings Inc. | 1.63 Billion USD | 47.411% |
| IMAC Holdings, Inc. | 1.14 Million USD | -75151.525% |
| biote Corp. | 155.29 Million USD | -454.407% |
| Cryo-Cell International, Inc. | 61.22 Million USD | -1306.332% |
| Cross Country Healthcare, Inc. | 679.31 Million USD | -26.74% |
| COMPASS Pathways plc | 275.98 Million USD | -211.959% |
| DocGo Inc. | 490.45 Million USD | -75.546% |
| The Ensign Group, Inc. | 4.17 Billion USD | 79.391% |
| Healthcare Services Group, Inc. | 803.18 Million USD | -7.195% |
| InnovAge Holding Corp. | 547.66 Million USD | -57.208% |
| Assure Holdings Corp. | 7.51 Million USD | -11358.171% |
| The Joint Corp. | 87.15 Million USD | -887.904% |
| LifeStance Health Group, Inc. | 2.23 Billion USD | 61.447% |
| Mobile-health Network Solutions Class A Ordinary Shares | 7.95 Million USD | -10728.936% |
| ModivCare Inc. | 1.76 Billion USD | 51.283% |
| NewGenIvf Group Limited | 1.64 Million USD | -52160.267% |
| Novo Integrated Sciences, Inc. | 35.56 Million USD | -2320.96% |
| Option Care Health, Inc. | 3.32 Billion USD | 74.132% |
| P3 Health Partners Inc. | 860.96 Million USD | 0.0% |
| The Pennant Group, Inc. | 539.69 Million USD | -59.53% |
| Surgery Partners, Inc. | 7.01 Billion USD | 87.734% |
| Syra Health Corp. Class A Common Stock | 4.92 Million USD | -17387.66% |
| Talkspace, Inc. | 142.22 Million USD | -505.373% |
| Talkspace, Inc. | 142.22 Million USD | -505.373% |
| The Oncology Institute, Inc. | 219.41 Million USD | -292.387% |
| The Oncology Institute, Inc. | 219.41 Million USD | -292.387% |